BINYAMINA, Israel, Feb. 1, 2023 /PRNewswire/ — OncoHost, a precision diagnostics company centered on predictive biomarker development for improved patient care, today announced the official launch of its PROphet® non-small lung cancer (NSCLC) Test in the United States.
Read more here.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://blog.ourcrowd.com/oncohost-launches-prophet-nsclc-cancer-test-in-the-united-states/